lithium carbonate has been researched along with Diabetes Mellitus, Type 1 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alpaslan, T; Bulent, C; Cengiz, T; Mithat, B | 1 |
| Berden, JH; Borggreven, JM; de Boo, T; De Pont, JJ; Elving, LD; Hovingh, A; van Norren, K; Willems, HL | 1 |
| Bech, P; Breum, L; Hammer, M; Jarløv, N; Raabaek Olsen, L; Schütze, T | 1 |
3 other study(ies) available for lithium carbonate and Diabetes Mellitus, Type 1
| Article | Year |
|---|---|
Risperidone-associated transient diabetic ketoacidosis and diabetes mellitus type 1 in a patient treated with valproate and lithium.
Topics: Adult; Antipsychotic Agents; Bipolar Disorder; Blood Glucose; Diabetes Mellitus, Type 1; Diabetic Ketoacidosis; Drug Therapy, Combination; Humans; Lithium Carbonate; Male; Risperidone; Severity of Illness Index; Valproic Acid | 2005 |
Comparison of methods for measurement of Na+/U+ countertransport across the erythrocyte membrane.
Topics: Antiporters; Diabetes Mellitus, Type 1; Erythrocyte Membrane; Humans; Individuality; Ionophores; Kinetics; Lithium; Lithium Carbonate; Lithium Chloride; Male; Nystatin; Reference Values; Sodium | 1997 |
A case of sequential anti-stress medication in a patient with major depression resistant to amine-reuptake inhibitors.
Topics: Amines; Antidepressive Agents; Anxiety Disorders; Dehydroepiandrosterone; Depressive Disorder, Major; Diabetes Mellitus, Type 1; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Fluoxetine; GABA Modulators; Humans; Hydrocortisone; Ketoconazole; Lithium Carbonate; Mianserin; Middle Aged; Oxazepam; Prognosis; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Severity of Illness Index; Stress, Psychological | 1999 |